West Pharmaceutical Services share price logo

West Pharmaceutical Services

NYSE: WST

Large Cap

$399.05

-9.73

(-2.38%)

Live

as on

West Pharmaceutical Services Stock Performance

as on November 6, 2026 at 4:21 am IST

  • Day's Low

    Day's High

    $398.87
    $409.80
    downward going graph

    0.05%

    Downside

    2.69%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $223.83
    $438.27
    downward going graph

    43.91%

    Downside

    9.83%

    Upside

    downward going graph

West Pharmaceutical Services share price movements today

Previous Close
$408.78
Open
$409.80
Volume
126.9K
Market Cap
$28.4B
Dividend Yield
0.22%
Day's Low - High
$398.87 - $409.80
52 Week Low - High
$223.83 - $438.27

West Pharmaceutical Services Historical Returns

1 Month Return
+ 8.5 %
3 Month Return
+ 16.45 %
1 Year Return
+ 44.17 %
3 Year Return
+ 22.02 %
5 Year Return
+ 1.24 %

West Pharmaceutical Services Stock Fundamentals & Key Indicators

Check West Pharmaceutical Services market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$28.4B

EPS (TTM)

8.97

Dividend Yield

0.22%

Quarterly Earnings Growth YOY

0.57%

PE Ratio (TTM)

45.37

Industry PE ratio

25.08

PEG Ratio

1.41

EBITDA

966.9M

Revenue (TTM)

3.4B

Profit Margin

37.59%

Return On Equity TTM

21.08%

West Pharmaceutical Services vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of West Pharmaceutical Services with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$28.4B1.24%45.3737.59%0.22%
StrongBuy$155.7B32.10%52.6667.19%0.00%
Neutral$37.0B-9.70%55.6756.45%0.50%
Neutral$54.1B-14.16%59.6946.12%2.01%
StrongBuy$45.9BNA39.6425.02%0.00%

Stock Returns calculator for West Pharmaceutical Services Stock including INR - Dollar returns

The West Pharmaceutical Services stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

West Pharmaceutical Services investment value today

Current value as on today

₹1,50,144

Returns

₹50,144

(+50.14%)

Returns from West Pharmaceutical Services Stock

₹40,739 (+40.74%)

Dollar Impact

₹9,405 (+9.41%)

Analyst Recommendation on West Pharmaceutical Services Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for West Pharmaceutical Services. Average target price of $471

West Pharmaceutical Services Share Price Target

Get share price movements and forecasts by analysts on West Pharmaceutical Services.

What analysts predicted

15.28%UPSIDE

Target Price

$471

Current Price

$399.05

Analyzed by

5 Analysts

High

$500

Target

$471.00

Low

$400

West Pharmaceutical Services target price $471, a slight upside of 15.28% compared to current price of $399.05. According to 5 analysts rating.

Indian Investors' Interest in West Pharmaceutical Services Stock

Search interest for West Pharmaceutical Services Stock has increased by 52% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:52% versus previous 30 day period

West Pharmaceutical Services Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
702
746
748
698
766
804
805
844
872
874
Gross Profit
231
265
274
232
273
293
303
296
329
347
Operating Income
130
167
170
128
158
173
156
177
179
267
EBITDA
169
205
205
150
198
217
209
218
225
313
Interest Expense
1
0
-
0
0
0
-
-
-
-
Depreciation
38
40
40
40
41
43
47
44
46
45
Income Before Tax
133
168
166
113
162
174
165
180
180
267
Income Tax Expense
21
32
36
24
30
34
33
44
32
58
Net Income
111
136
130
89
131
140
132
138
154
214
Net Profit Margin
32.95%
35.51%
36.66%
33.33%
35.66%
36.49%
37.75%
35.08%
37.74%
39.73%

West Pharmaceutical Services Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1,600
1,718
1,843
2,146
2,830
2,885
2,951
2,892
3,073
Gross Profit
514
546
608
767
1,173
1,138
1,132
1,002
1,103
Operating Income
229
254
297
419
758
763
710
594
617
EBITDA
326
353
403
518
879
808
844
743
770
Interest Expense
7
8
8
8
8
7
8
2
0
Depreciation
96
104
103
109
122
120
137
155
171
Income Before Tax
231
248
300
418
769
700
715
600
615
Income Tax Expense
80
41
59
72
107
114
122
107
121
Net Income
150
206
241
346
661
585
593
492
493
Net Profit Margin
32.17%
31.80%
33.02%
35.77%
41.45%
39.47%
38.38%
34.65%
35.89%

West Pharmaceutical Services Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
111
136
130
89
131
140
132
138
154
214
Operating Cash Flow
165
180
190
129
177
197
251
89
124
189
Investing Cash Flow
-101
-82
-104
-71
-75
-63
-76
-42
-43
78
Financing Cash Flow
-218
-64
-68
-147
-14
-11
-11
-308
-164
-241
Change in Cash
-155
44
-6
-80
105
118
162
-269
-85
28

West Pharmaceutical Services Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
150
206
241
346
661
585
593
492
493
Operating Cash Flow
263
288
367
472
584
724
776
653
754
Investing Cash Flow
-133
-100
-228
-179
-253
-288
-368
-378
-285
Financing Cash Flow
-109
-80
-36
-137
-168
-293
-459
-622
-185
Change in Cash
32
101
101
176
147
131
-40
-369
306

Global Institutional Holdings in West Pharmaceutical Services

Check out the Institutions with significant holdings in West Pharmaceutical Services.

Funds
Holdings
Vanguard
12.02%
VANGUARD INDEX FUNDS
10.29%
BlackRock, Inc.
9.55%
iShares
5.59%
SPDR
4.21%

West Pharmaceutical Services News & Key Events

  • img

    Today's Timeline - 01 November

    Mon, 00:38 AM

    -

    West Pharmaceutical Services reports Q3 results, raises 2026 sales guidance, and signs new credit agreement for increased liquidity.

Insights on West Pharmaceutical Services

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 7 quarters, 698.20M → 874.50M (in $), with an average increase of 3.6% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, WST has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, WST stock has moved up by 16.5%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 132.10M → 214.00M (in $), with an average increase of 14.2% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, WST has outperformed top 5 stocks with highest market-cap in its industry

About West Pharmaceutical Services

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
OrganisationWest Pharmaceutical Services
Headquarters530 Herman O. West Drive, Exton, PA, 19341-1147, US
IndustryMedical - Instruments & Supplies
CEOMichel Lagarde

Key Management of West Pharmaceutical Services

Name

Title

Mr. Chad R. Winters

VP of Finance & Chief Accounting Officer

Dr. Devesh Mathur

Senior VP & CTO

Mr. Robert W. McMahon C.M.A.

Senior VP & CFO

Ms. Annette F. Favorite

Chief HR Officer & Senior VP

Mr. Shane A. Campbell

SVP & Chief Proprietary Segment Officer

Mr. Michel Lagarde

President, CEO & Director

Mr. Norman D. Finch Jr.

Senior VP, General Counsel & Corporate Secretary

Ms. Michele Polinsky

Vice President of Global Communications

Mr. Rudy J. Poussot

Senior Vice President of Strategy & Corporate Development

Ms. Kathy DePadua

Senior VP and Chief Quality & Regulatory Officer

FAQs

What is West Pharmaceutical Services share price today?

West Pharmaceutical Services share price today is $399.05 as on . West Pharmaceutical Services share today touched a day high of $409.80 and a low of $398.87.

What is the 52 week high and 52 week low for West Pharmaceutical Services share?

West Pharmaceutical Services share touched a 52 week high of $438.27 on and a 52 week low of $223.83 on . West Pharmaceutical Services stock price today i.e. is trending at $399.05,which is 8.95% down from its 52 week high and 78.28% up from its 52 week low.

What is West Pharmaceutical Services's market capitalisation today?

West Pharmaceutical Services market capitalisation is $0.03T as on .

How to invest in West Pharmaceutical Services Stock (WST) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for West Pharmaceutical Services on INDmoney app. Click on Buy button.

What is the minimum amount required to buy West Pharmaceutical Services Stock (WST) from India?

Indian investors can start investing in West Pharmaceutical Services (WST) shares with as little as ₹94.4749984741211 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in West Pharmaceutical Services stock (as per the Rupee-Dollar exchange rate as on ). Based on West Pharmaceutical Services share’s latest price of $399.05 as on November 5, 2026 at 10:51 pm IST, you will get 0.0251 shares of West Pharmaceutical Services. Learn more about fractional shares .

What are the returns that West Pharmaceutical Services has given to Indian investors in the last 5 years?

West Pharmaceutical Services stock has given 1.24% share price returns and 27.92% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?